Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Amazon
AMZN
|
$429M |
| 2 |
Gilead Sciences
GILD
|
$303M |
| 3 |
Visa
V
|
$256M |
| 4 |
Meta Platforms (Facebook)
META
|
$218M |
| 5 |
Union Pacific
UNP
|
$211M |
Top Sells
| 1 |
McDonald's
MCD
|
$351M |
| 2 |
SWY
SAFEWAY INC
SWY
|
$210M |
| 3 |
TSMC
TSM
|
$174M |
| 4 |
GSK
GSK
|
$157M |
| 5 |
Johnson & Johnson
JNJ
|
$148M |
Sector Composition
| 1 | Healthcare | 13.05% |
| 2 | Technology | 11.88% |
| 3 | Consumer Discretionary | 11.2% |
| 4 | Industrials | 10.91% |
| 5 | Consumer Staples | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Telus
TU
$24.9B
| $104M | 0.22% |
3,134,300
+188,100
| +6% | +$6.25M |
|
77
Aptiv
APTV
$17.4B
| $103M | 0.22% |
1,297,400
+1,078,500
| +493% | +$86M |
|
|
SPLS
78
DELISTED
Staples Inc
SPLS
| $102M | 0.22% |
+6,277,679
| New | +$102M |
|
79
Clorox
CLX
$15B
| $101M | 0.21% |
913,500
-308,500
| -25% | -$34.1M |
|
|
MJN
80
DELISTED
Mead Johnson Nutrition Company
MJN
| $99M | 0.21% |
985,000
+432,800
| +78% | +$43.5M |
|
81
National Grid
NGG
$67.8B
| $98.7M | 0.21% |
1,527,700
+17,200
| +1% | +$1.11M |
|
82
O'Reilly Automotive
ORLY
$87.5B
| $98M | 0.21% |
453,094
+74,900
| +20% | +$16.2M |
|
83
Edwards Lifesciences
EW
$47.8B
| $95.2M | 0.2% |
668,400
+183,900
| +38% | +$26.2M |
|
84
Bausch Health
BHC
$2.8B
| $94.5M | 0.2% |
475,837
+436,848
| +1,120% | +$86.7M |
|
85
Baidu
BIDU
$33.1B
| $94.2M | 0.2% |
451,900
+170,400
| +61% | +$35.5M |
|
86
EchoStar
SATS
$18.4B
| $93.1M | 0.2% |
1,800,980
+8,800
| +0.5% | +$455K |
|
87
American Express
AXP
$230B
| $92.7M | 0.2% |
+1,186,600
| New | +$92.7M |
|
88
PPG Industries
PPG
$24.7B
| $92.2M | 0.2% |
+409,000
| New | +$92.2M |
|
89
Macerich
MAC
$4.57B
| $92.2M | 0.2% |
1,092,964
+421,464
| +63% | +$35.5M |
|
90
Usana Health Sciences
USNA
$581M
| $91.3M | 0.19% |
821,583
+23,700
| +3% | +$2.63M |
|
91
Pfizer
PFE
$142B
| $91.2M | 0.19% |
+2,622,441
| New | +$91.2M |
|
92
DuPont de Nemours
DD
$31.7B
| $90.4M | 0.19% |
+1,884,800
| New | +$90.4M |
|
|
NTT
93
DELISTED
Nippon Telegraph & Telephone
NTT
| $89M | 0.19% |
2,886,320
-512,380
| -15% | -$15.8M |
|
|
94
Johnson & Johnson
JNJ
$426B
| $87.2M | 0.19% |
867,200
-1,469,500
| -63% | -$148M |
|
95
Entergy
ETR
$38.9B
| $85.7M | 0.18% |
1,106,100
+138,700
| +14% | +$10.7M |
|
96
Ultrapar
UGP
$3.92B
| $85.5M | 0.18% |
4,233,700
-175,800
| -4% | -$3.55M |
|
97
Procter & Gamble
PG
$368B
| $85.5M | 0.18% |
1,043,128
-1,692,771
| -62% | -$139M |
|
98
Sealed Air
SEE
$4.75B
| $85.1M | 0.18% |
1,868,100
+1,719,500
| +1,157% | +$78.3M |
|
|
PCYC
99
DELISTED
PHARMACYCLICS INC
PCYC
| $84.9M | 0.18% |
331,700
+223,700
| +207% | +$57.3M |
|
100
Zoetis
ZTS
$67.4B
| $84.4M | 0.18% |
1,822,794
+1,172,294
| +180% | +$54.3M |
|